Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
NLI Holdings
NL
$289M
| $790K | ﹤0.01% |
216,504
+12,503
| +6% | +$45.4K |
|
2802
ACM Research
ACMR
$4.51B
| $787K | ﹤0.01% |
+151,200
| New | +$876K |
|
2803
RGC Resources
RGCO
$233M
| $787K | ﹤0.01% |
25,778
+10,078
| +64% | +$273K |
|
|
ACGN
2804
DELISTED
Aceragen Inc
ACGN
| $787K | ﹤0.01% |
17,348
+2,442
| +16% | +$116K |
|
2805
BioXcel Therapeutics
BTAI
$24.8M
| $785K | ﹤0.01% |
4,475
+1,675
| +60% | +$284K |
|
2806
Vanguard Information Technology ETF
VGT
$133B
| $780K | ﹤0.01% |
29,600
+16,000
| +118% | +$413K |
|
2807
Vanguard Mid-Cap Value ETF
VOE
$23.9B
| $779K | ﹤0.01% |
7,000
+3,300
| +89% | +$361K |
|
2808
Lifetime Brands
LCUT
$192M
| $778K | ﹤0.01% |
82,200
-600
| -0.7% | -$5.48K |
|
2809
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.22B
| $772K | ﹤0.01% |
+3,100
| New | +$683K |
|
|
TRT
2810
Trio-Tech International
TRT
$92M
| $772K | ﹤0.01% |
535,960
-44,000
| -8% | -$69.1K |
|
2811
Cadiz
CDZI
$251M
| $771K | ﹤0.01% |
+68,500
| New | +$699K |
|
|
MEET
2812
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $771K | ﹤0.01% |
221,554
+178,362
| +413% | +$792K |
|
2813
Dorchester Minerals
DMLP
$1.3B
| $770K | ﹤0.01% |
42,075
-17,399
| -29% | -$327K |
|
2814
Quest Resource Holding
QRHC
$27.6M
| $770K | ﹤0.01% |
277,824
+9,441
| +4% | +$21.6K |
|
|
FOMX
2815
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $770K | ﹤0.01% |
323,600
+306,200
| +1,760% | +$915K |
|
|
DCOY
2816
Decoy Therapeutics
DCOY
$2.14M
| $769K | ﹤0.01% |
2
| – | – |
|
2817
Transportadora de Gas del Sur
TGS
$4.48B
| $768K | ﹤0.01% |
+55,176
| New | +$664K |
|
2818
Vanguard Growth ETF
VUG
$212B
| $768K | ﹤0.01% |
+28,200
| New | +$753K |
|
2819
Vanguard Financials ETF
VFH
$13.4B
| $766K | ﹤0.01% |
+11,100
| New | +$753K |
|
|
UQM
2820
DELISTED
UQM Technologies, Inc.
UQM
| $765K | ﹤0.01% |
463,899
+384,200
| +482% | +$633K |
|
2821
Simpson Manufacturing
SSD
$7.79B
| $764K | ﹤0.01% |
11,500
-77,900
| -87% | -$4.98M |
|
2822
Metallus
MTUS
$833M
| $764K | ﹤0.01% |
+93,938
| New | +$850K |
|
2823
Invesco CEF Income Composite ETF
PCEF
$788M
| $763K | ﹤0.01% |
33,700
+12,300
| +57% | +$275K |
|
|
STI
2824
DELISTED
SunTrust Banks, Inc.
STI
| $760K | ﹤0.01% |
+12,100
| New | +$760K |
|
2825
Plug Power
PLUG
$2.65B
| $759K | ﹤0.01% |
337,131
-1,798,669
| -84% | -$4.46M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.